PubMed ID: 31153849 Author(s): Holmen IC, Aul B, Pak JW, Trane RM, Blodi B, Klein M, Clemons T, Chew E, Domalpally A; Age-Related Eye Disease Study 2 Research Group. Precursors and development of geographic atrophy …
WRC
Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial.
PubMed ID: 31169862 Author(s): Scott IU, VanVeldhuisen PC, Barton F, Oden NL, Ip MS, Blodi BA, Worrall M, Fish GE; Study of Comparative Treatments for Retinal Vein Occlusion 2 Investigator Group. Patient-reported visual function outcomes …
TWO CASES OF ACUTE RETINAL NECROSIS DUE TO VARICELLA ZOSTER DESPITE PRIOR SHINGLES VACCINATION.
PubMed ID: 28291069 Author(s): Weinlander EJ, Wang AL, Jaru-Ampornpan P, Altaweel MM, Nork TM. Two cases of acute retinal necrosis due to varicella zoster despite prior shingles vaccination. Retin Cases Brief Rep. 2019 Summer;13(3):241-243. doi: …
Comparative Intraoperative Anterior Segment OCT Findings in Pediatric Patients with and without Glaucoma.
PubMed ID: 32672544 Author(s): Bradfield Y, Barbosa T, Blodi B, Tompson SW, McLellan GJ, Struck M, Young TL. Comparative intraoperative anterior segment OCT findings in pediatric patients with and without glaucoma. Ophthalmol Glaucoma. 2019 Jul …
Comparative Intraoperative Anterior Segment OCT Findings in Pediatric Patients with and without Glaucoma.
PubMed ID: 32672544 Author(s): Bradfield Y, Barbosa T, Blodi B, Tompson SW, McLellan GJ, Struck M, Young TL. Comparative intraoperative anterior segment OCT findings in pediatric patients with and without glaucoma. Ophthalmol Glaucoma. 2019 Jul …
Imaging Characteristics of Choroidal Neovascular Lesions in the AREDS2-HOME Study: Report Number 4.
PubMed ID: 31014685 Author(s): Domalpally A, Clemons TE, Bressler SB, Danis RP, Elman M, Kim JE, Brown D, Chew EY. Imaging characteristics of choroidal neovascular lesions in the AREDS2-HOME study: report number 4. Ophthalmol Retina. …
Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study.
PubMed ID: 30589922 Author(s): Ip MS, Oden NL, Scott IU, VanVeldhuisen PC, Blodi BA, Ghuman T, Baker CW; SCORE2 Investigator Group. Month 12 outcomes after treatment change at month 6 among poor responders to aflibercept …
Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.
PubMed ID: 30142373 Author(s): Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY; Age-Related Eye Disease Study 2 Research Group. Natural history of drusenoid pigment epithelial detachment …
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
PubMed ID: 30269924 Author(s): Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA; Multicenter Uveitis Steroid Treatment Trial Research Group. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. …